SOURCE: Telzuit Medical Technologies, Inc.

May 03, 2007 14:08 ET

Telzuit Medical Technologies: Orders Received

ORLANDO, FL -- (MARKET WIRE) -- May 3, 2007 -- Telzuit Medical Technologies, Inc. (OTCBB: TZMT)

--  The Company will ship 250 patches to its nursing home client at the
    end of May 2007
--  The Company's physician office distributor will begin to receive
    product in the middle of June
    

Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced that it will begin shipping product in late May to its collaborator servicing nursing homes and in the middle of June to one of its physician offices distributors. After a number of years of development and the corrections made to the product design over the last year, Telzuit is ready to roll out the product.

We can not yet predict how quickly the STATPATCH System will be accepted by the market and will not ramp up production until we can predict the uptake of the product.

Warren Stowell, CEO of Telzuit, stated that the Company has had to rework the product in its entirety which has resulted in significant delays in full scale entry into the market. "I am very pleased with the progress we have made and we are now ready to begin a new phase in the Company's life."

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http/www.telzuit.com

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:

    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc.
    407-354-1222